• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年全球、区域和国家软组织及骨外肉瘤负担

Global, regional, and national burden of soft tissue and extraosseous sarcomas from 1990 to 2021.

作者信息

Chen Cheng, Wang Cheng, Li ShiJie, Zheng Xu, Yang YunFeng

机构信息

Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai 200233, China.

出版信息

Prev Med Rep. 2024 Oct 17;47:102903. doi: 10.1016/j.pmedr.2024.102903. eCollection 2024 Nov.

DOI:10.1016/j.pmedr.2024.102903
PMID:39498209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533684/
Abstract

OBJECTIVE

To conduct a comprehensive global epidemiological investigation of soft tissue and extraosseous sarcomas from 1990 to 2021 and uncover the demographic and geographical variations.

METHODS

Incidence and death data of soft tissue and extraosseous sarcomas between 1990 and 2021 were derived from the Global Burden of Disease 2021. The estimated annual percentage change was calculated. The demographic patterns were analyzed in-depth based on age and gender.

RESULTS

From 1990 to 2021, there was an increase in the number and crude rate of incidence and death of soft tissue and extraosseous sarcomas, while age-standardized rate declined. Males consistently exhibited a heavier burden compared to females. The incidence and death rates of soft tissue and extraosseous sarcomas generally increased with age, with a similar pattern in both males and females. Compared to 1990, the incidence rate among the elderly increased in 2021, while the incidence rate in children under 5 decreased, and there was little change in other age groups. The death rate among children and the elderly has decreased, while little change in other age groups has been observed.

CONCLUSIONS

The disease burden of soft tissue and extraosseous sarcomas remains a critical challenge. Data-driven analysis is crucial for guiding clinical practice, informing public health policies, and shaping future research agendas.

摘要

目的

对1990年至2021年期间的软组织和骨外肉瘤进行全面的全球流行病学调查,揭示人口统计学和地理差异。

方法

1990年至2021年期间软组织和骨外肉瘤的发病率和死亡率数据来自《2021年全球疾病负担》。计算了估计的年度百分比变化。基于年龄和性别对人口统计学模式进行了深入分析。

结果

1990年至2021年期间,软组织和骨外肉瘤的发病数、粗发病率和死亡率均有所上升,而年龄标准化率下降。男性的负担始终比女性更重。软组织和骨外肉瘤的发病率和死亡率一般随年龄增长而上升,男性和女性的模式相似。与1990年相比,2021年老年人的发病率上升,而5岁以下儿童的发病率下降,其他年龄组变化不大。儿童和老年人的死亡率有所下降,而其他年龄组变化不大。

结论

软组织和骨外肉瘤的疾病负担仍然是一项严峻挑战。数据驱动的分析对于指导临床实践、为公共卫生政策提供信息以及制定未来研究议程至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/6242aab8c0a1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/f973a32bdf55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/d480bd4e9ce1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/4cd005f3b050/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/ca499aaa3f90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/6242aab8c0a1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/f973a32bdf55/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/d480bd4e9ce1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/4cd005f3b050/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/ca499aaa3f90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e69/11533684/6242aab8c0a1/gr5.jpg

相似文献

1
Global, regional, and national burden of soft tissue and extraosseous sarcomas from 1990 to 2021.1990年至2021年全球、区域和国家软组织及骨外肉瘤负担
Prev Med Rep. 2024 Oct 17;47:102903. doi: 10.1016/j.pmedr.2024.102903. eCollection 2024 Nov.
2
Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: Results from the Global Burden of Disease study 2019.全球、区域和国家非风湿性瓣膜性心脏病的发病率、死亡率和伤残调整生命年,以及 1990 年至 2019 年的趋势分析:来自 2019 年全球疾病负担研究的结果。
Asian Cardiovasc Thorac Ann. 2023 Oct;31(8):706-722. doi: 10.1177/02184923231200695. Epub 2023 Sep 7.
3
What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019.1990 年至 2019 年髋部骨折的流行病学和全球疾病负担是怎样的?来自 2019 年全球疾病负担研究的结果及进一步分析。
Clin Orthop Relat Res. 2023 Jun 1;481(6):1209-1220. doi: 10.1097/CORR.0000000000002465. Epub 2022 Nov 2.
4
Global, regional, and national total burden related to hepatitis B in children and adolescents from 1990 to 2021.全球、区域和国家层面 1990 年至 2021 年与儿童和青少年乙型肝炎相关的总负担。
BMC Public Health. 2024 Oct 23;24(1):2936. doi: 10.1186/s12889-024-20462-4.
5
A systematic analysis on global epidemiology and burden of foot fracture over three decades.对三十年来足部骨折的全球流行病学和负担的系统分析。
Chin J Traumatol. 2025 May;28(3):208-215. doi: 10.1016/j.cjtee.2024.03.001. Epub 2024 Mar 7.
6
Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study.肢体软组织肉瘤:基于全国人口研究的描述性流行病学分析
Arch Bone Jt Surg. 2022 Jan;10(1):67-77. doi: 10.22038/ABJS.2021.53750.2676.
7
Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年全球、区域和国家的地中海贫血负担:全球疾病负担研究2021的系统分析
EClinicalMedicine. 2024 May 6;72:102619. doi: 10.1016/j.eclinm.2024.102619. eCollection 2024 Jun.
8
Analysis of Trends in Race and Gender Disparities in Incidence-Based Mortality in Patients Diagnosed with Soft Tissue Sarcomas from 2000 to 2016.2000年至2016年诊断为软组织肉瘤患者基于发病率的死亡率的种族和性别差异趋势分析
Int J Gen Med. 2021 Jul 24;14:3787-3791. doi: 10.2147/IJGM.S296309. eCollection 2021.
9
Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study.1990年至2019年全球、区域和国家骨关节炎伤残调整生命年(DALYs)趋势:全球疾病负担研究的综合分析
Public Health. 2024 Jan;226:261-272. doi: 10.1016/j.puhe.2023.10.030. Epub 2023 Dec 21.
10
Bone and Soft Tissue Sarcoma Epidemiology in Iranian Elderly Population; an Analysis of the Iranian National Registry for Cancer (2009-2014 Years).伊朗老年人群中的骨与软组织肉瘤流行病学;对伊朗国家癌症登记处(2009 - 2014年)的分析
Iran J Public Health. 2024 Jul;53(7):1670-1680. doi: 10.18502/ijph.v53i7.16061.

本文引用的文献

1
A clinical tool to predict overall survival of elderly patients with soft tissue sarcoma after surgical resection.一种用于预测接受手术切除的老年软组织肉瘤患者总体生存的临床工具。
Sci Rep. 2024 Jul 2;14(1):15098. doi: 10.1038/s41598-024-65657-2.
2
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
3
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
4
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
5
Demographic and clinical profile of 1106 adult soft tissue sarcoma patients: A single institutional prospective database experience from India.1106 例成人软组织肉瘤患者的人口统计学和临床特征:来自印度的单机构前瞻性数据库经验。
Asia Pac J Clin Oncol. 2024 Jun;20(3):386-394. doi: 10.1111/ajco.14050. Epub 2024 Feb 21.
6
Gender Differences in Soft Tissue and Bone Sarcoma: A Narrative Review.软组织和骨肉瘤的性别差异:一项叙述性综述
Cancers (Basel). 2023 Dec 31;16(1):201. doi: 10.3390/cancers16010201.
7
Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan.日本非城市地区的骨和软组织肉瘤的治疗方法和预后因素。
Int J Clin Oncol. 2024 Mar;29(3):345-353. doi: 10.1007/s10147-023-02453-4. Epub 2023 Dec 28.
8
Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and Costs.软组织肉瘤的性别差异:发病率、临床病理特征、生存和费用。
J Womens Health (Larchmt). 2023 Nov;32(11):1257-1264. doi: 10.1089/jwh.2023.0019. Epub 2023 Oct 11.
9
SOFT TISSUE SARCOMA - SANTA CASA DE SÃO PAULO EXPERIENCE FROM 2006 TO 2019.软组织肉瘤——圣保罗圣卡塔琳娜医院2006年至2019年的经验
Acta Ortop Bras. 2023 Jul 17;31(3):e263799. doi: 10.1590/1413-785220233103e263799. eCollection 2023.
10
Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service.2013 年至 2017 年英格兰软组织肉瘤的发病率和生存率:来自国家癌症登记和分析服务的分析。
Int J Cancer. 2023 May 1;152(9):1789-1803. doi: 10.1002/ijc.34409. Epub 2023 Jan 11.